CN109248217A - 一种治疗烧烫伤的膏剂及其制备方法 - Google Patents
一种治疗烧烫伤的膏剂及其制备方法 Download PDFInfo
- Publication number
- CN109248217A CN109248217A CN201811289197.XA CN201811289197A CN109248217A CN 109248217 A CN109248217 A CN 109248217A CN 201811289197 A CN201811289197 A CN 201811289197A CN 109248217 A CN109248217 A CN 109248217A
- Authority
- CN
- China
- Prior art keywords
- parts
- paste
- scald
- burn
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010053615 Thermal burn Diseases 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 239000000203 mixture Substances 0.000 claims abstract description 46
- 239000003814 drug Substances 0.000 claims abstract description 38
- 229910052602 gypsum Inorganic materials 0.000 claims abstract description 29
- 239000010440 gypsum Substances 0.000 claims abstract description 29
- 239000000843 powder Substances 0.000 claims abstract description 29
- 239000011782 vitamin Substances 0.000 claims abstract description 28
- 229940088594 vitamin Drugs 0.000 claims abstract description 28
- HKIKAXXIWJHWLY-ZIIYPAMZSA-N Aloesin Chemical compound C=12OC(CC(=O)C)=CC(=O)C2=C(C)C=C(O)C=1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HKIKAXXIWJHWLY-ZIIYPAMZSA-N 0.000 claims abstract description 25
- HKIKAXXIWJHWLY-QEVGBQTESA-N Aloesin Natural products O=C(CC=1Oc2c([C@H]3[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O3)c(O)cc(C)c2C(=O)C=1)C HKIKAXXIWJHWLY-QEVGBQTESA-N 0.000 claims abstract description 25
- WLOHNSSYAXHWNR-NXPDYKKBSA-N dirithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H]2O[C@H](COCCOC)N[C@H]([C@@H]2C)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 WLOHNSSYAXHWNR-NXPDYKKBSA-N 0.000 claims abstract description 22
- 229960004100 dirithromycin Drugs 0.000 claims abstract description 22
- 239000004166 Lanolin Substances 0.000 claims abstract description 17
- 229940039717 lanolin Drugs 0.000 claims abstract description 17
- 235000019388 lanolin Nutrition 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- 239000006071 cream Substances 0.000 claims description 21
- 238000001914 filtration Methods 0.000 claims description 21
- 235000019441 ethanol Nutrition 0.000 claims description 15
- -1 filtration Substances 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 15
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 14
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 14
- 239000006228 supernatant Substances 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 7
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 7
- 241000205585 Aquilegia canadensis Species 0.000 claims description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 7
- 235000013717 Houttuynia Nutrition 0.000 claims description 7
- 244000246386 Mentha pulegium Species 0.000 claims description 7
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 7
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 7
- 229930003268 Vitamin C Natural products 0.000 claims description 7
- 229930003427 Vitamin E Natural products 0.000 claims description 7
- 229940116229 borneol Drugs 0.000 claims description 7
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 7
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- 235000001050 hortel pimenta Nutrition 0.000 claims description 7
- 235000019154 vitamin C Nutrition 0.000 claims description 7
- 239000011718 vitamin C Substances 0.000 claims description 7
- 235000019165 vitamin E Nutrition 0.000 claims description 7
- 229940046009 vitamin E Drugs 0.000 claims description 7
- 239000011709 vitamin E Substances 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 2
- 239000000463 material Substances 0.000 claims 2
- 244000025254 Cannabis sativa Species 0.000 claims 1
- 240000000691 Houttuynia cordata Species 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 239000008280 blood Substances 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 7
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 5
- 230000001114 myogenic effect Effects 0.000 abstract description 5
- 230000036407 pain Effects 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 4
- 241000894006 Bacteria Species 0.000 abstract description 3
- 206010048038 Wound infection Diseases 0.000 abstract description 3
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 3
- 238000001035 drying Methods 0.000 abstract description 3
- 238000010926 purge Methods 0.000 abstract description 3
- 239000003053 toxin Substances 0.000 abstract description 3
- 231100000765 toxin Toxicity 0.000 abstract description 3
- 230000000202 analgesic effect Effects 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 abstract description 2
- 238000005469 granulation Methods 0.000 abstract description 2
- 230000003179 granulation Effects 0.000 abstract description 2
- 230000003020 moisturizing effect Effects 0.000 abstract description 2
- 230000017074 necrotic cell death Effects 0.000 abstract description 2
- 230000029663 wound healing Effects 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 9
- 235000004256 Buglossoides arvense Nutrition 0.000 description 7
- 241000118841 Lithospermum incisum Species 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 241000758769 Houttuynia Species 0.000 description 6
- 206010052428 Wound Diseases 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000003643 water by type Substances 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 210000004209 hair Anatomy 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 206010031009 Oral pain Diseases 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000002924 anti-infective effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- 206010008528 Chillblains Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 208000032456 Hemorrhagic Shock Diseases 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 206010049771 Shock haemorrhagic Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000001266 bandaging Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 239000009416 jing wan hong Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000008354 sodium chloride injection Substances 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- PSGGLQPNTOVNKU-UHFFFAOYSA-N tetrakis(pyridine)silver(ii) peroxydisulfate Chemical compound [Ag].C1=CC=NC=C1.C1=CC=NC=C1.C1=CC=NC=C1.C1=CC=NC=C1 PSGGLQPNTOVNKU-UHFFFAOYSA-N 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗烧烫伤的膏剂,涉及医药技术领域,为了解决现有药品止痛慢,换药时易发生粘连、疼痛感强和创面愈合时间长的问题,包括以下原料:白凡士林、羊毛脂、螺旋霉素、地红霉素、芦荟苦素、复合维生素、珍珠粉、煅石膏、中药组合物,本发明还公开了所述治疗烧烫伤的膏剂的制备方法,本发明制备的治疗烧烫伤的膏剂去腐生肌、疏散风热、消炎抑菌、清热燥湿、泻火解毒、散瘀止痛具有良好的效果,通过加入螺旋霉素、地红霉素、芦荟苦素能够迅速杀死各种细菌,防止伤口感染,通过加入复合维生素、珍珠粉和煅石膏,能够起到润肤生肌的效果,使皮肤保持弹性,通过加入中药组合物,各中药各尽其效,相互促进,大大减轻了病人痛苦。
Description
技术领域
本发明涉及医药技术领域,具体是一种治疗烧烫伤的膏剂及其制备方法。
背景技术
烧伤、烫伤、灼伤、创伤是日常生活中最常见的意外事故之一,事故发生常常致使外表皮肤局部小面积损伤,大面积损伤则可引起全身性的病变。常威胁到人类的健康和生命的安全。烧创伤创面的愈合是医学界一个复杂而又有序的过程,常常涉及组织生物学和细胞生物学,通过受损部位邻近组织和细胞再生而修复,其过程常涉及到多种炎症介质、生长因子、炎症细胞、细胞外基质和修复细胞等分子的共同参与,创面的愈合在机体的调控下具有精密的有序性、网络型和完整性。而祖国医学认为皮肤损伤致使防御失职,固摄无权导致津液外泄、邪毒内侵、表卫损伤,则卫气营血调和失控,致肌肤筋脉失养;创伤、冻疮、褥疮及皮肤溃疡亦多因肌肤组织受损,局部气血运行受阻,气滞血淤而造成血肉腐败,上述各种损伤等疾病。
目前对于烧伤的治疗,主要采用无菌包扎治疗,或用人工皮覆盖创面包扎治疗面积较大的烧伤;面积较小、程度较轻的烧伤用湿润烧伤膏、紫草烧伤液、京万红软膏、磺胺嘧啶银等外用制剂治疗。前述中药外用制剂治疗小面积、轻度烧伤患者具有较好的临床效果,但还是存有止痛慢,换药时易发生粘连、疼痛感强和创面愈合时间长的问题;不能满足人们治疗中、小面积烧伤的需要。
发明内容
本发明的目的在于提供一种治疗烧烫伤的膏剂及其制备方法,以解决上述背景技术中提出的问题。
为实现上述目的,本发明提供如下技术方案:
一种治疗烧烫伤的膏剂,包括以下按照重量份的原料:白凡士林200-300份、羊毛脂30-50份、螺旋霉素20-30份、地红霉素30-40份、芦荟苦素10-20份、复合维生素25-35份、珍珠粉40-50份、煅石膏20-40份、中药组合物50-60份。
作为本发明进一步的方案:包括以下按照重量份的原料:白凡士林220-280份、羊毛脂35-45份、螺旋霉素22-28份、地红霉素32-38份、芦荟苦素12-18份、复合维生素28-32份、珍珠粉42-48份、煅石膏25-35份、中药组合物52-58份。
作为本发明进一步的方案:包括以下按照重量份的原料:白凡士林250份、羊毛脂40份、螺旋霉素25份、地红霉素25份、芦荟苦素15份、复合维生素30份、珍珠粉45份、煅石膏30份、中药组合物55份。
作为本发明进一步的方案:所述复合维生素由维生素C和维生素E按照质量比为1:2混合而成。
作为本发明进一步的方案:所述中药组合物由黄柏、紫草、冰片、薄荷、黄芩、连翘、金银花、地榆炭、鱼腥草等比例混合而成。
作为本发明进一步的方案:所述治疗烧烫伤的膏剂的制备方法,步骤如下:
1)按配比称取各原料;
2)将中药组合物加5-10倍重量水量煎煮2-4小时,滤过,滤液浓缩,接着加入6-8倍重量的乙醇水溶液,静置20-30小时,上清液过滤,加热挥去乙醇,再加入8-12倍重量的水,静置10-20小时,取上清液过滤,得清膏;
3)将螺旋霉素、地红霉素、芦荟苦素、复合维生素加入步骤2)得到的清膏中,并充分搅拌均匀,得到混合物A;
4)将煅石膏进行充分粉碎,过180-220目筛,备用;
5)将混合物A、煅石膏粉末、白凡士林、羊毛脂、珍珠粉合并,搅拌均匀,得到所需膏剂。
作为本发明进一步的方案:所述乙醇水溶液中乙醇的体积浓度为70%。
与现有技术相比,本发明的有益效果是:本发明制备的治疗烧烫伤的膏剂去腐生肌、疏散风热、消炎抑菌、清热燥湿、泻火解毒、散瘀止痛具有良好的效果,通过加入螺旋霉素、地红霉素、芦荟苦素能够迅速杀死各种细菌,防止伤口感染,通过加入复合维生素、珍珠粉和煅石膏,能够起到润肤生肌的效果,使皮肤保持弹性,通过加入中药组合物,各中药各尽其效,相互促进,形成了一个清热、镇痛、凉血、消炎、解毒、抗感染、生肌、敛疮口的索链,以达到最终目的—疮口痊愈,大大减轻了病人痛苦,具有广阔的市场前景。
具体实施方式
下面将结合具体实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1
本发明实施例中,一种治疗烧烫伤的膏剂,包括以下按照重量份的原料:白凡士林200份、羊毛脂30份、螺旋霉素20份、地红霉素30份、芦荟苦素10份、复合维生素25份、珍珠粉40份、煅石膏20份、中药组合物50份。
其中,所述复合维生素由维生素C和维生素E按照质量比为1:2混合而成。
所述中药组合物由黄柏、紫草、冰片、薄荷、黄芩、连翘、金银花、地榆炭、鱼腥草等比例混合而成。
本实施例中,所述治疗烧烫伤的膏剂的制备方法,步骤如下:
1)按配比称取各原料;
2)将中药组合物加5倍重量水量煎煮2小时,滤过,滤液浓缩,接着加入6倍重量的乙醇水溶液,静置20小时,上清液过滤,加热挥去乙醇,再加入8倍重量的水,静置10小时,取上清液过滤,得清膏;
3)将螺旋霉素、地红霉素、芦荟苦素、复合维生素加入步骤2)得到的清膏中,并充分搅拌均匀,得到混合物A;
4)将煅石膏进行充分粉碎,过180目筛,备用;
5)将混合物A、煅石膏粉末、白凡士林、羊毛脂、珍珠粉合并,搅拌均匀,得到所需膏剂。
上述乙醇水溶液中乙醇的体积浓度为70%。
实施例2
本发明实施例中,一种治疗烧烫伤的膏剂,包括以下按照重量份的原料:白凡士林220份、羊毛脂35份、螺旋霉素22份、地红霉素32份、芦荟苦素12份、复合维生素28份、珍珠粉42份、煅石膏25份、中药组合物52份。
其中,所述复合维生素由维生素C和维生素E按照质量比为1:2混合而成。
所述中药组合物由黄柏、紫草、冰片、薄荷、黄芩、连翘、金银花、地榆炭、鱼腥草等比例混合而成。
本实施例中,所述治疗烧烫伤的膏剂的制备方法,步骤如下:
1)按配比称取各原料;
2)将中药组合物加6倍重量水量煎煮2小时,滤过,滤液浓缩,接着加入6倍重量的乙醇水溶液,静置22小时,上清液过滤,加热挥去乙醇,再加入9倍重量的水,静置12小时,取上清液过滤,得清膏;
3)将螺旋霉素、地红霉素、芦荟苦素、复合维生素加入步骤2)得到的清膏中,并充分搅拌均匀,得到混合物A;
4)将煅石膏进行充分粉碎,过190目筛,备用;
5)将混合物A、煅石膏粉末、白凡士林、羊毛脂、珍珠粉合并,搅拌均匀,得到所需膏剂。
上述乙醇水溶液中乙醇的体积浓度为70%。
实施例3
本发明实施例中,一种治疗烧烫伤的膏剂,包括以下按照重量份的原料:白凡士林250份、羊毛脂40份、螺旋霉素25份、地红霉素25份、芦荟苦素15份、复合维生素30份、珍珠粉45份、煅石膏30份、中药组合物55份。
其中,所述复合维生素由维生素C和维生素E按照质量比为1:2混合而成。
所述中药组合物由黄柏、紫草、冰片、薄荷、黄芩、连翘、金银花、地榆炭、鱼腥草等比例混合而成。
本实施例中,所述治疗烧烫伤的膏剂的制备方法,步骤如下:
1)按配比称取各原料;
2)将中药组合物加8倍重量水量煎煮3小时,滤过,滤液浓缩,接着加入7倍重量的乙醇水溶液,静置25小时,上清液过滤,加热挥去乙醇,再加入10倍重量的水,静置15小时,取上清液过滤,得清膏;
3)将螺旋霉素、地红霉素、芦荟苦素、复合维生素加入步骤2)得到的清膏中,并充分搅拌均匀,得到混合物A;
4)将煅石膏进行充分粉碎,过200目筛,备用;
5)将混合物A、煅石膏粉末、白凡士林、羊毛脂、珍珠粉合并,搅拌均匀,得到所需膏剂。
上述乙醇水溶液中乙醇的体积浓度为70%。
实施例4
本发明实施例中,一种治疗烧烫伤的膏剂,包括以下按照重量份的原料:白凡士林280份、羊毛脂45份、螺旋霉素28份、地红霉素38份、芦荟苦素18份、复合维生素32份、珍珠粉48份、煅石膏35份、中药组合物58份。
其中,所述复合维生素由维生素C和维生素E按照质量比为1:2混合而成。
所述中药组合物由黄柏、紫草、冰片、薄荷、黄芩、连翘、金银花、地榆炭、鱼腥草等比例混合而成。
本实施例中,所述治疗烧烫伤的膏剂的制备方法,步骤如下:
1)按配比称取各原料;
2)将中药组合物加9倍重量水量煎煮4小时,滤过,滤液浓缩,接着加入8倍重量的乙醇水溶液,静置28小时,上清液过滤,加热挥去乙醇,再加入11倍重量的水,静置18小时,取上清液过滤,得清膏;
3)将螺旋霉素、地红霉素、芦荟苦素、复合维生素加入步骤2)得到的清膏中,并充分搅拌均匀,得到混合物A;
4)将煅石膏进行充分粉碎,过210目筛,备用;
5)将混合物A、煅石膏粉末、白凡士林、羊毛脂、珍珠粉合并,搅拌均匀,得到所需膏剂。
上述乙醇水溶液中乙醇的体积浓度为70%。
实施例5
本发明实施例中,一种治疗烧烫伤的膏剂,包括以下按照重量份的原料:白凡士林300份、羊毛脂50份、螺旋霉素30份、地红霉素40份、芦荟苦素20份、复合维生素35份、珍珠粉50份、煅石膏40份、中药组合物60份。
其中,所述复合维生素由维生素C和维生素E按照质量比为1:2混合而成。
所述中药组合物由黄柏、紫草、冰片、薄荷、黄芩、连翘、金银花、地榆炭、鱼腥草等比例混合而成。
本实施例中,所述治疗烧烫伤的膏剂的制备方法,步骤如下:
1)按配比称取各原料;
2)将中药组合物加10倍重量水量煎煮4小时,滤过,滤液浓缩,接着加入8倍重量的乙醇水溶液,静置30小时,上清液过滤,加热挥去乙醇,再加入12倍重量的水,静置20小时,取上清液过滤,得清膏;
3)将螺旋霉素、地红霉素、芦荟苦素、复合维生素加入步骤2)得到的清膏中,并充分搅拌均匀,得到混合物A;
4)将煅石膏进行充分粉碎,过220目筛,备用;
5)将混合物A、煅石膏粉末、白凡士林、羊毛脂、珍珠粉合并,搅拌均匀,得到所需膏剂。
上述乙醇水溶液中乙醇的体积浓度为70%。
对比例1
与实施例3相比,不含芦荟苦素,其他与实施例3相同。
对比例2
与实施例3相比,不含地榆炭,其他其他与实施例3相同。
对比例3
与实施例3相比,不含芦荟苦素和地榆炭,其他其他与实施例3相同。
性能验证
选择小鼠120只,6周龄,雄雌各半,体重20±2g,小鼠在恒定的室温24℃和湿度60wt%条件下适应性喂养一周,分成6组小鼠每组20只,雌雄各半,腹腔注射10wt%水合氯醛麻醉,8wt%硫化钠溶液进行上背部的脱毛2cm*4cm,24h后,小鼠局部外用70wt%乙醇消毒脱毛区,将酒精灯点燃,将小鼠脱毛区置于外焰上端2cm处10s后移开,建立小鼠深二度烧伤模型,造模后腹腔注射0.9wt%氯化钠注射液2mL以抗休克,然后6组小鼠分别用棉签擦拭对比例1-3及实施例1-3配制好的膏剂后按摩,每日两次,间隔12h,连续给药28d,观察小鼠烫伤处炎症感染情况、痊愈情况,实验结果如下表:
组别 | 炎症感染 | 痊愈 | 有效率 |
对比例1 | 4 | 16 | 84 |
对比例2 | 4 | 16 | 84 |
对比例3 | 8 | 12 | 60 |
实施例1 | 1 | 19 | 95 |
实施例2 | 1 | 19 | 95 |
实施例3 | 0 | 20 | 100 |
以上结果可以看出,本发明制备的膏剂能够有效治疗烧烫伤,通过芦荟苦素和地榆炭具有协同增益效果,本发明制备的治疗烧烫伤的膏剂去腐生肌、疏散风热、消炎抑菌、清热燥湿、泻火解毒、散瘀止痛具有良好的效果,通过加入螺旋霉素、地红霉素、芦荟苦素能够迅速杀死各种细菌,防止伤口感染,通过加入复合维生素、珍珠粉和煅石膏,能够起到润肤生肌的效果,使皮肤保持弹性,通过加入中药组合物,各中药各尽其效,相互促进,形成了一个清热、镇痛、凉血、消炎、解毒、抗感染、生肌、敛疮口的索链,以达到最终目的—疮口痊愈,大大减轻了病人痛苦,具有广阔的市场前景。
对于本领域技术人员而言,显然本发明不限于上述示范性实施例的细节,而且在不背离本发明的精神或基本特征的情况下,能够以其他的具体形式实现本发明。因此,无论从哪一点来看,均应将实施例看作是示范性的,而且是非限制性的,本发明的范围由所附权利要求而不是上述说明限定,因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本发明内。
此外,应当理解,虽然本说明书按照实施方式加以描述,但并非每个实施方式仅包含一个独立的技术方案,说明书的这种叙述方式仅仅是为清楚起见,本领域技术人员应当将说明书作为一个整体,各实施例中的技术方案也可以经适当组合,形成本领域技术人员可以理解的其他实施方式。
Claims (8)
1.一种治疗烧烫伤的膏剂,其特征在于,包括以下按照重量份的原料:白凡士林200-300份、羊毛脂30-50份、螺旋霉素20-30份、地红霉素30-40份、芦荟苦素10-20份、复合维生素25-35份、珍珠粉40-50份、煅石膏20-40份、中药组合物50-60份。
2.根据权利要求1所述的治疗烧烫伤的膏剂,其特征在于,包括以下按照重量份的原料:白凡士林220-280份、羊毛脂35-45份、螺旋霉素22-28份、地红霉素32-38份、芦荟苦素12-18份、复合维生素28-32份、珍珠粉42-48份、煅石膏25-35份、中药组合物52-58份。
3.根据权利要求2所述的治疗烧烫伤的膏剂,其特征在于,包括以下按照重量份的原料:白凡士林250份、羊毛脂40份、螺旋霉素25份、地红霉素25份、芦荟苦素15份、复合维生素30份、珍珠粉45份、煅石膏30份、中药组合物55份。
4.根据权利要求1所述的治疗烧烫伤的膏剂,其特征在于,所述复合维生素由维生素C和维生素E按照质量比为1:2混合而成。
5.根据权利要求1所述的治疗烧烫伤的膏剂,其特征在于,所述中药组合物由黄柏、紫草、冰片、薄荷、黄芩、连翘、金银花、地榆炭、鱼腥草等比例混合而成。
6.如权利要求1-5任一所述的治疗烧烫伤的膏剂的制备方法,其特征在于,步骤如下:
1)按配比称取各原料;
2)将中药组合物加5-10倍重量水量煎煮2-4小时,滤过,滤液浓缩,接着加入6-8倍重量的乙醇水溶液,静置20-30小时,上清液过滤,加热挥去乙醇,再加入8-12倍重量的水,静置10-20小时,取上清液过滤,得清膏;
3)将螺旋霉素、地红霉素、芦荟苦素、复合维生素加入步骤2)得到的清膏中,并充分搅拌均匀,得到混合物A;
4)将煅石膏进行充分粉碎,过180-220目筛,备用;
5)将混合物A、煅石膏粉末、白凡士林、羊毛脂、珍珠粉合并,搅拌均匀,得到所需膏剂。
7.根据权利要求6所述的治疗烧烫伤的膏剂的制备方法,其特征在于,所述乙醇水溶液中乙醇的体积浓度为70%。
8.如权利要求1-5任一所述的治疗烧烫伤的膏剂在制备治疗烧烫伤产品中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811289197.XA CN109248217A (zh) | 2018-10-31 | 2018-10-31 | 一种治疗烧烫伤的膏剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811289197.XA CN109248217A (zh) | 2018-10-31 | 2018-10-31 | 一种治疗烧烫伤的膏剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109248217A true CN109248217A (zh) | 2019-01-22 |
Family
ID=65044454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811289197.XA Withdrawn CN109248217A (zh) | 2018-10-31 | 2018-10-31 | 一种治疗烧烫伤的膏剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109248217A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111036442A (zh) * | 2019-10-08 | 2020-04-21 | 吉林大学 | 一种用于动物试验脱毛过程的棉签处理器 |
-
2018
- 2018-10-31 CN CN201811289197.XA patent/CN109248217A/zh not_active Withdrawn
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111036442A (zh) * | 2019-10-08 | 2020-04-21 | 吉林大学 | 一种用于动物试验脱毛过程的棉签处理器 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2018137319A1 (zh) | 大叶清香桂的应用,治疗皮肤病的中药膏剂、制备方法及其应用 | |
CN109248217A (zh) | 一种治疗烧烫伤的膏剂及其制备方法 | |
CN101164600A (zh) | 一种治疗痤疮、青春痘的药物 | |
CN103007034B (zh) | 用于治疗ⅱ度烧伤残余创面的中药组合物及制备方法 | |
CN104225106A (zh) | 一种适用于人畜的无痕烫伤膏及其制备方法 | |
CN109260355A (zh) | 一种治疗和改善银屑病的组合物和制备方法与应用 | |
CN102846799A (zh) | 烧烫伤中药外用膏及其制备方法 | |
CN105031254B (zh) | 一种治疗皮炎的膏剂及其制备方法 | |
CN108721442B (zh) | 治疗烧烫伤及尿布皮炎的中药组合物、制剂及其制备方法 | |
WO2018000727A1 (zh) | 一种治疗接触性皮炎的复方制剂及制备方法 | |
CN100350934C (zh) | 一种白癜消中药组合物及其制备方法 | |
CN105456708B (zh) | 一种用于治疗口唇炎的药物及其制备方法 | |
CN105168091A (zh) | 一种祛红血丝面膜粉及其制备方法 | |
CN100423767C (zh) | 一种治疗烧、烫伤的药物及其制备方法 | |
CN102266361A (zh) | 烧烫伤植皮膏及其制备方法 | |
CN107951933A (zh) | 祛痤疮药膜及其制备方法 | |
CN107693714A (zh) | 一种修颜护肤的中药组合物及其制备方法和应用 | |
CN102727794A (zh) | 一种用于治疗烧伤烫伤、跌打损伤和风湿骨痛的中药处方 | |
CN101647938B (zh) | 一种治疗烧烫伤的药物及其制备方法 | |
CN107029158A (zh) | 一种治疗家兔疥癣病的复方中草药外用制剂 | |
CN105287977A (zh) | 一种罗勒、芦荟组合物、制剂及其制备方法和应用 | |
CN105560581A (zh) | 医治冻疮的中药酊及其制法 | |
CN105343266A (zh) | 治疗牛皮癣的药膏 | |
CN104784285A (zh) | 一种治疗酒渣鼻的中药膏剂 | |
CN104740140A (zh) | 一种治疗烧烫伤的护理药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20190122 |